Cargando…
The Use of External Controls in FDA Regulatory Decision Making
The regulatory standards of the United States Food and Drug Administration (FDA) require substantial evidence of effectiveness from adequate and well-controlled trials that typically use a valid comparison to an internal concurrent control. However, when it is not feasible or ethical to use an inter...
Autores principales: | Jahanshahi, Mahta, Gregg, Keith, Davis, Gillian, Ndu, Adora, Miller, Veronica, Vockley, Jerry, Ollivier, Cecile, Franolic, Tanja, Sakai, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332598/ https://www.ncbi.nlm.nih.gov/pubmed/34014439 http://dx.doi.org/10.1007/s43441-021-00302-y |
Ejemplares similares
-
Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs
por: Drago, Daniela, et al.
Publicado: (2021) -
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis
por: Costa, Enrico, et al.
Publicado: (2022) -
The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
por: Gherghescu, Ioana, et al.
Publicado: (2020) -
Introducción a la navegación astronómica /
por: Franolic, Petar
Publicado: (1997) -
Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)